Screening for Genetic Forms of Diabetes in Convention of Care for Children and Adolescents With Diabetes (GENEPEDIAB)

Plain-language summary

This study evaluates screening for genetic forms of diabetes, particularly MODY, in children and adolescents with diabetes. Patients aged 0-18 at the time of diabetes diagnosis who were followed at participating pediatric endocrinology departments were included. It was carried out as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Université Catholique de Louvain

Intervention

Mody test

Start date

10/22/2018

Estimated completion

6/22/2022

Countries

Belgium

Related genes

Locations

• Brussels, Belgium

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Age between 0 and 18 years at the age of diabetes diagnosis.
* Patients followed and/or diagnosed within diabetes care agreements of the pediatric endocrinology departments participating in the study.

Exclusion Criteria:

* none